Skip to main content
Year archive

Pharma Equity Group A/S — 2023 filings

All 58 regulatory filings released by Pharma Equity Group A/S (BLVIS) in 2023, sourced directly from the official regulator.

58 Filings
2023 Period
2023 filings (58)
Filing Released Lang
Legal Proceedings Report 2023
Legal Proceedings Report
2023-11-28 English
Legal Proceedings Report 2023
Legal Proceedings Report
2023-11-28 Danish
Status of the Company's receivable from Portinho S.A.
Regulatory Filings
2023-11-28 Danish
Status of the Company's receivable from Portinho S.A.
Regulatory Filings
2023-11-28 Danish
Regulatory Filings 2023
Regulatory Filings
2023-11-16 English
Legal Proceedings Report 2023
Legal Proceedings Report
2023-11-16 Danish
Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) meets the primary endpoints in the phase-2 clinical trial of the drug candidate RNX-051.
Regulatory Filings
2023-11-16 Danish
Pharma Equity Group’s subsidiary (Reponex Pharmaceuticals A/S) meets the primary endpoints in the phase-2 clinical trial of the drug candidate RNX-051.
Regulatory Filings
2023-11-16 Danish
Regulatory Filings 2023
Regulatory Filings
2023-10-31 English
Regulatory Filings 2023
Regulatory Filings
2023-10-31 Danish
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) receives a notification from the EPO regarding the “Intention to Grant” for patents of the subsidiary's wound-healing drug combination an
Regulatory Filings
2023-10-31 Danish
Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) receives a notification from the EPO regarding the “Intention to Grant” for patents of the subsidiary's wound-healing drug combination an
Regulatory Filings
2023-10-31 English
Regulatory Filings 2023
Regulatory Filings
2023-10-31 English
Regulatory Filings 2023
Regulatory Filings
2023-10-31 Danish
Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing composition.
Regulatory Filings
2023-10-31 English
Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing composition.
Regulatory Filings
2023-10-31 English
Legal Proceedings Report 2023
Legal Proceedings Report
2023-09-25 English
Legal Proceedings Report 2023
Legal Proceedings Report
2023-09-25 Danish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-16 English
Consolidated interim report 1 January – 30 June 2023
Interim / Quarterly Report H1 2023
2023-08-16 English
Regulatory Filings 2023
Regulatory Filings
2023-08-15 Danish
Regulatory Filings 2023
Regulatory Filings
2023-08-15 English
Legal Proceedings Report 2023
Legal Proceedings Report
2023-06-30 Danish
Regulatory Filings 2023
Regulatory Filings
2023-06-30 English
Board/Management Information 2023
Board/Management Information
2023-06-15 English
Regulatory Filings 2023
Regulatory Filings
2023-06-08 English
Transaction in Own Shares 2023
Transaction in Own Shares
2023-06-02 English
Director's Dealing 2023
Director's Dealing
2023-05-25 English
Board/Management Information 2023
Board/Management Information
2023-04-21 Danish
Board/Management Information 2023
Board/Management Information
2023-03-31 Danish
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-03-31 Danish
Remuneration Information 2023
Remuneration Information
2023-03-31 Danish
Pharma Equity Group A/S - Årsrapport 2022
Annual Report FY 2022
2023-03-31 Danish
Pharma Equity Group A/S - Årsrapport 2022
Report Publication Announcement
2023-03-31 Danish
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-30 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-30 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-30 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-30 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-25 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-24 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-03-24 Danish
Earnings Release 2023
Earnings Release FY 2023
2023-03-24 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-03-24 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-03-21 Danish
Approval of prospectus for Pharma Equity Group A/S; Shares
Share Issue/Capital Change
2023-03-08 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-01-31 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change
2023-01-25 Danish
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement
2023-01-19 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-19 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-18 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-18 Danish
Blue Vision A/S – indberetning af ledende medarbejders og disses nærtståendes transaktioner
Director's Dealing
2023-01-18 Danish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-18 Danish
Capital/Financing Update 2023
Capital/Financing Update
2023-01-17 Danish